Crown Advisors Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,000	Closed	-$319K	–	50
2022 Q3	$319K	Buy	+30,000	New	+$319K	0.32%	43